Search results
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 6 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoCAR-T drugs are developed using a patient's own immune cells. Promisingly, Pfizer said in February...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 7 days agoThe three vaccines updated to target the SARS-CoV-2 XBB.1.5 subvariant -- Moderna's and Pfizer-BioNTech's mRNA vaccines and the Novavax ...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 2 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 2 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 5 days agoThe authors said the findings underscore the need for new boosters. Next week, the Center for...
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 4 days agoModerna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines, has hit a new milestone: its first non-Covid product, which...
Here are the organizations that Ken Paxton targeted using consumer protection laws
The Texas Tribune· 6 days agoAlso, sign up for The Brief, our daily newsletter that keeps readers up to speed on the most...
US Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says
Forbes· 6 days agoCiting unnamed people close to the discussion, the Financial Times reported federal funding worth...